ReP USP - Resultado da busca

Artigo de periodico
Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study (2024)
Pinto, Jairo Vinicius Merege de Mello Cruz; Crippa, José Alexandre de Souza ; Ceresér, Keila Maria; Vianna-Sulzbach, Miréia Fortes; Silveira Júnior, Érico de Moura; Rosa, Gabriel Santana da; Silva, Manoella Guatimuzim Testa da; Hizo, Gabriel Henrique; Medeiros, Leonardo Simão; Oliveira, Carlos Eduardo Santana de; Bristot, Giovana; Campos, Alline Cristina de ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Yatham, Lakshmi N.; Kapczinski, Flávio; Kauer-Sant’anna, Márcia
Fonte: The Canadian Journal of Psychiatry. Unidades: FMRP, ESALQ
Assuntos: TRANSTORNO BIPOLAR, HUMOR, DEPRESSÃO, CANNABIS, CANABINOIDES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Jairo Vinicius Merege de Mello Cruz et al. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, v. 69, n. 4, p. 242-251, 2024Tradução . . Disponível em: https://doi.org/10.1177/07067437231209650. Acesso em: 08 jul. 2024.
APA
Pinto, J. V. M. de M. C., Crippa, J. A. de S., Ceresér, K. M., Vianna-Sulzbach, M. F., Silveira Júnior, É. de M., Rosa, G. S. da, et al. (2024). Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, 69( 4), 242-251. doi:10.1177/07067437231209650
NLM
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant’anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1177/07067437231209650
Vancouver
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant’anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1177/07067437231209650
Artigo de periodico-carta/editorial
Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] (2023)
Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio
Fonte: Brazilian Journal of Psychiatry. Unidade: FMRP
Assuntos: CANABINOIDES, CANNABIS, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-0047. Acesso em: 08 jul. 2024. , 2023
APA
Crippa, J. A. de S., Guimarães, F. S., Zuardi, A. W., & Hallak, J. E. C. (2023). Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-0047
NLM
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2024 jul. 08 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Vancouver
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2024 jul. 08 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Artigo de periodico
Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats (2023)
Cavichioli, Andreza M.; Silva, Thamyris Santos; Grace, Anthony A.; Guimarães, Francisco Silveira ; Gomes, Felipe Villela
Fonte: Schizophrenia Bulletin. Unidade: FMRP
Assuntos: POTENCIAIS DE AÇÃO, NEUROTRANSMISSORES, ESQUIZOFRENIA, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVICHIOLI, Andreza M. et al. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, v. 49, n. 1, p. 68-77, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbac106. Acesso em: 08 jul. 2024.
APA
Cavichioli, A. M., Silva, T. S., Grace, A. A., Guimarães, F. S., & Gomes, F. V. (2023). Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats. Schizophrenia Bulletin, 49( 1), 68-77. doi:10.1093/schbul/sbac106
NLM
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1093/schbul/sbac106
Vancouver
Cavichioli AM, Silva TS, Grace AA, Guimarães FS, Gomes FV. Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats [Internet]. Schizophrenia Bulletin. 2023 ; 49( 1): 68-77.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1093/schbul/sbac106
Artigo de periodico
Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (2022)
Souza, Adriana de Jesus; Cortez, Isadora L.; Silva, Nicole R.; Pedrazzi, João Francisco Cordeiro; Domingos, Luana B.; Braga, Matheus Silva; Silva, Thamyris Santos; Del Bel, Elaine Aparecida ; Resstel, Leonardo Barbosa Moraes ; Li, Guanguan; Mian, Md Yeunus; Sharmin, Dishary; Guimarães, Francisco Silveira ; Cook, James M.; Gomes, Felipe Villela
Fonte: Behavioural Brain Research. Unidades: FORP, FMRP
Assuntos: ANSIEDADE, DEPRESSÃO, ANTIPSICÓTICOS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Adriana de Jesus et al. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, v. 428, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2022.113832. Acesso em: 08 jul. 2024.
APA
Souza, A. de J., Cortez, I. L., Silva, N. R., Pedrazzi, J. F. C., Domingos, L. B., Braga, M. S., et al. (2022). Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors. Behavioural Brain Research, 428, 1-11. doi:10.1016/j.bbr.2022.113832
NLM
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Vancouver
Souza A de J, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Silva TS, Del Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABAA receptors [Internet]. Behavioural Brain Research. 2022 ; 428 1-11.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.bbr.2022.113832
Artigo de periodico
Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity (2022)
Carvalho, Renata K.; Rocha, Thiago L.; Fernandes, Fábio H.; Gonçalves, Bruno B.; Souza, Maingredy R.; Araújo, Amanda A.; Barbosa, Caio C.; Silva, Daniela M.; Campos, Hericles M.; Tomazett, Mariana V.; Ghedini, Paulo C.; Guimarães, Francisco Silveira ; Andersen, Monica L.; Santos, Fernanda C. A.; Costa, Renata Mazaro
Fonte: Chemico-Biological Interactions. Unidades: FMRP, FCF
Assuntos: CANABINOIDES, DANO AO DNA, ESPERMATOGÊNESE, ESPERMATOZOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Renata K. et al. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity. Chemico-Biological Interactions, v. 351, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2021.109743. Acesso em: 08 jul. 2024.
APA
Carvalho, R. K., Rocha, T. L., Fernandes, F. H., Gonçalves, B. B., Souza, M. R., Araújo, A. A., et al. (2022). Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity. Chemico-Biological Interactions, 351. doi:10.1016/j.cbi.2021.109743
NLM
Carvalho RK, Rocha TL, Fernandes FH, Gonçalves BB, Souza MR, Araújo AA, Barbosa CC, Silva DM, Campos HM, Tomazett MV, Ghedini PC, Guimarães FS, Andersen ML, Santos FCA, Costa RM. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity [Internet]. Chemico-Biological Interactions. 2022 ; 351[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.cbi.2021.109743
Vancouver
Carvalho RK, Rocha TL, Fernandes FH, Gonçalves BB, Souza MR, Araújo AA, Barbosa CC, Silva DM, Campos HM, Tomazett MV, Ghedini PC, Guimarães FS, Andersen ML, Santos FCA, Costa RM. Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: new insights of cannabidiol-mediated male reproductive toxicity [Internet]. Chemico-Biological Interactions. 2022 ; 351[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.cbi.2021.109743
Artigo de periodico
Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice (2022)
Ribeiro, Melissa A.; Aguiar, Rafael P.; Scarante, Franciele Franco ; Fusse, Eduardo J.; Oliveira, Rubia M. W. de; Guimarães, Francisco Silveira ; Campos, Alline Cristina de
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: ESTRESSE, ANTIDEPRESSIVOS, HIPOCAMPO, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Melissa A. et al. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Frontiers in Pharmacology, v. 12, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.805758. Acesso em: 08 jul. 2024.
APA
Ribeiro, M. A., Aguiar, R. P., Scarante, F. F., Fusse, E. J., Oliveira, R. M. W. de, Guimarães, F. S., & Campos, A. C. de. (2022). Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Frontiers in Pharmacology, 12, 1-14. doi:10.3389/fphar.2021.805758
NLM
Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, Oliveira RMW de, Guimarães FS, Campos AC de. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-14.[citado 2024 jul. 08 ] Available from: https://doi.org/10.3389/fphar.2021.805758
Vancouver
Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, Oliveira RMW de, Guimarães FS, Campos AC de. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-14.[citado 2024 jul. 08 ] Available from: https://doi.org/10.3389/fphar.2021.805758
Artigo de periodico
Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction (2022)
Franzen, Jaqueline M.; Vanz, Felipe; Werle, Isabel; Guimarães, Francisco Silveira ; Bertoglio, Leandro J.
Fonte: European Neuropsychopharmacology. Unidades: FMRP, ICB
Assuntos: CANABINOIDES, MEMÓRIA, SAÚDE MENTAL, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANZEN, Jaqueline M. et al. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction. European Neuropsychopharmacology, v. 64, p. 7-18, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2022.08.002. Acesso em: 08 jul. 2024.
APA
Franzen, J. M., Vanz, F., Werle, I., Guimarães, F. S., & Bertoglio, L. J. (2022). Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction. European Neuropsychopharmacology, 64, 7-18. doi:10.1016/j.euroneuro.2022.08.002
NLM
Franzen JM, Vanz F, Werle I, Guimarães FS, Bertoglio LJ. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction [Internet]. European Neuropsychopharmacology. 2022 ; 64 7-18.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.euroneuro.2022.08.002
Vancouver
Franzen JM, Vanz F, Werle I, Guimarães FS, Bertoglio LJ. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction [Internet]. European Neuropsychopharmacology. 2022 ; 64 7-18.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.euroneuro.2022.08.002
Artigo de periodico
The Cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPARγ receptors (2022)
Silva, Nicole Rodrigues; Gomes, Francisco Isaac Fernandes; Lopes, Alexandre Hashimoto Pereira; Cortez, Isadora Lopes; Santos, Jéssica Cristina dos; Silva, Conceição Elidianne Aníbal; Mechoulam, Raphael; Gomes, Felipe Villela ; Cunha, Thiago Mattar; Guimarães, Francisco Silveira
Fonte: Neurotherapeutics. Unidade: FMRP
Assuntos: ANTINEOPLÁSICOS, CANABINOIDES, GÂNGLIOS ESPINHAIS, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Nicole Rodrigues et al. The Cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPARγ receptors. Neurotherapeutics, v. 19, n. 1, p. 434-449, 2022Tradução . . Disponível em: https://doi.org/10.1007/s13311-021-01164-w. Acesso em: 08 jul. 2024.
APA
Silva, N. R., Gomes, F. I. F., Lopes, A. H. P., Cortez, I. L., Santos, J. C. dos, Silva, C. E. A., et al. (2022). The Cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPARγ receptors. Neurotherapeutics, 19( 1), 434-449. doi:10.1007/s13311-021-01164-w
NLM
Silva NR, Gomes FIF, Lopes AHP, Cortez IL, Santos JC dos, Silva CEA, Mechoulam R, Gomes FV, Cunha TM, Guimarães FS. The Cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPARγ receptors [Internet]. Neurotherapeutics. 2022 ; 19( 1): 434-449.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1007/s13311-021-01164-w
Vancouver
Silva NR, Gomes FIF, Lopes AHP, Cortez IL, Santos JC dos, Silva CEA, Mechoulam R, Gomes FV, Cunha TM, Guimarães FS. The Cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPARγ receptors [Internet]. Neurotherapeutics. 2022 ; 19( 1): 434-449.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1007/s13311-021-01164-w
Artigo de periodico
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments (2022)
Bayer, Hugo; Stern, Cristina A. J.; Troyner, Fernanda; Gazarini, Lucas; Guimarães, Francisco Silveira ; Bertoglio, Leandro J.
Fonte: Neuropharmacology. Unidade: FMRP
Assuntos: COMPORTAMENTO, CANABINOIDES, TRANSTORNOS DA MEMÓRIA, FARMACOTERAPIA, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAYER, Hugo et al. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, v. 205, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108913. Acesso em: 08 jul. 2024.
APA
Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2022). Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, 205, 1-11. doi:10.1016/j.neuropharm.2021.108913
NLM
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Vancouver
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Artigo de periodico
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia (2022)
Cortez, Isadora Lopes; Silva, Nicole R.; Rodrigues, Naielly S.; Pedrazzi, João Francisco Cordeiro; Del Bel, Elaine Aparecida ; Mechoulam, Raphael; Gomes, Felipe Villela ; Guimarães, Francisco Silveira
Fonte: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FORP, FMRP
Assuntos: CANABINOIDES, ESQUIZOFRENIA, FARMACOTERAPIA, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Isadora Lopes et al. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 117, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2022.110553. Acesso em: 08 jul. 2024.
APA
Cortez, I. L., Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Del Bel, E. A., Mechoulam, R., et al. (2022). HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 1-9. doi:10.1016/j.pnpbp.2022.110553
NLM
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Vancouver
Cortez IL, Silva NR, Rodrigues NS, Pedrazzi JFC, Del Bel EA, Mechoulam R, Gomes FV, Guimarães FS. HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2022 ; 117 1-9.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2022.110553
Artigo de periodico
Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects (2021)
Sartim, Ariandra Guerini; Marques, J.; Silveira, Kennia Moura; Nunes, Pedro Henrique Gobira; Guimarães, Francisco Silveira ; Wegener, G.; Wegener, Sâmia Regiane Lourenço Joca
Fonte: Neuropharmacology. Unidades: FMRP, FCFRP
Assuntos: ANTIDEPRESSIVOS, COMPORTAMENTO ANIMAL, CANABINOIDES, DEPRESSÃO, HIPOCAMPO, ATIVIDADE MOTORA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTIM, Ariandra Guerini et al. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, v. 195, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108679. Acesso em: 08 jul. 2024.
APA
Sartim, A. G., Marques, J., Silveira, K. M., Nunes, P. H. G., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2021). Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, 195. doi:10.1016/j.neuropharm.2021.108679
NLM
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Vancouver
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Artigo de periodico
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats (2021)
Estela, Airam Nicole Vivanco; Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Nascimento, Glauce Crivelaro do
Fonte: Neuropharmacology. Unidades: FORP, FMRP
Assuntos: CANABINOIDES, ANALGÉSICOS, ANTICONVULSIVANTES, DOR FACIAL, NOCICEPTIVIDADE, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTELA, Airam Nicole Vivanco et al. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108700. Acesso em: 08 jul. 2024.
APA
Estela, A. N. V., Pereira, M. dos S., Guimarães, F. S., Del Bel, E. A., & Nascimento, G. C. do. (2021). Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108700
NLM
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Vancouver
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Artigo de periodico
Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments (2021)
Mori, Marco Aurélio; Meyer, Erika; Silva, Francielly F.; Milani, Humberto; Guimarães, Francisco Silveira ; Oliveira, Rúbia Maria Weffort de
Fonte: European Journal of Neuroscience. Unidade: FMRP
Assuntos: CANABINOIDES, ISQUEMIA, SEROTONINA, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Marco Aurélio et al. Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments. European Journal of Neuroscience, v. 53, n. 6, p. 1738-1751, 2021Tradução . . Disponível em: https://doi.org/10.1111/ejn.15134. Acesso em: 08 jul. 2024.
APA
Mori, M. A., Meyer, E., Silva, F. F., Milani, H., Guimarães, F. S., & Oliveira, R. M. W. de. (2021). Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments. European Journal of Neuroscience, 53( 6), 1738-1751. doi:10.1111/ejn.15134
NLM
Mori MA, Meyer E, Silva FF, Milani H, Guimarães FS, Oliveira RMW de. Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments [Internet]. European Journal of Neuroscience. 2021 ; 53( 6): 1738-1751.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1111/ejn.15134
Vancouver
Mori MA, Meyer E, Silva FF, Milani H, Guimarães FS, Oliveira RMW de. Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments [Internet]. European Journal of Neuroscience. 2021 ; 53( 6): 1738-1751.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1111/ejn.15134
Artigo de periodico
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? (2021)
Salviato, Beatriz Zanutto; Raymundi, Ana Maria; Silva, Thiago Rodrigues da; Salemme, Bruna Wuilleumier; Sohn, Jeferson Machado Batista; Araújo, Fabiano Soares; Guimarães, Francisco Silveira ; Bertoglio, Leandro José; Stern, Cristina Aparecida
Fonte: Neuropharmacology. Unidade: FMRP
Assuntos: DIFERENÇAS SEXUAIS (PSICOGÊNESE), CANABINOIDES, ANSIOLÍTICOS, ANSIEDADE, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALVIATO, Beatriz Zanutto et al. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108684. Acesso em: 08 jul. 2024.
APA
Salviato, B. Z., Raymundi, A. M., Silva, T. R. da, Salemme, B. W., Sohn, J. M. B., Araújo, F. S., et al. (2021). Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108684
NLM
Salviato BZ, Raymundi AM, Silva TR da, Salemme BW, Sohn JMB, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108684
Vancouver
Salviato BZ, Raymundi AM, Silva TR da, Salemme BW, Sohn JMB, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108684
Artigo de periodico
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum (2021)
Pedrazzi, João Francisco Cordeiro; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Joca, Sâmia Regiane Lourenço ; Crippa, José Alexandre de Souza ; Del Bel, Elaine Aparecida
Fonte: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FCFRP, FORP
Assuntos: ANFETAMINAS, ANTIPSICÓTICOS, COMPORTAMENTO ANIMAL, CANABINOIDES, METILAÇÃO DE DNA, CÓRTEX PRÉ-FRONTAL, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2021.110352. Acesso em: 08 jul. 2024.
APA
Pedrazzi, J. F. C., Sales, A. J., Guimarães, F. S., Joca, S. R. L., Crippa, J. A. de S., & Del Bel, E. A. (2021). Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111. doi:10.1016/j.pnpbp.2021.110352
NLM
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Vancouver
Pedrazzi JFC, Sales AJ, Guimarães FS, Joca SRL, Crippa JA de S, Del Bel EA. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110352
Artigo de periodico
Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy (2021)
Perez, Matheus; Cartarozzi, Luciana Politti; Chiarotto, Gabriela Bortolança; Guimarães, Francisco Silveira ; Oliveira, Alexandre Leite Rodrigues de
Fonte: Neuropharmacology. Unidades: EEFERP, FMRP
Assuntos: AXÔNIOS, CANABINOIDES, NEURÔNIOS MOTORES, NERVOS PERIFÉRICOS, NERVO CIÁTICO, NERVOS ESPINHAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Matheus et al. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology, v. 197, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108726. Acesso em: 08 jul. 2024.
APA
Perez, M., Cartarozzi, L. P., Chiarotto, G. B., Guimarães, F. S., & Oliveira, A. L. R. de. (2021). Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology, 197. doi:10.1016/j.neuropharm.2021.108726
NLM
Perez M, Cartarozzi LP, Chiarotto GB, Guimarães FS, Oliveira ALR de. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108726
Vancouver
Perez M, Cartarozzi LP, Chiarotto GB, Guimarães FS, Oliveira ALR de. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108726
Artigo de periodico
PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice (2021)
Sonego, Andreza Buzolin ; Prado, Douglas da Silva; Guimarães, Francisco Silveira
Fonte: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidade: FMRP
Assuntos: DISCINESIAS, ANTIPSICÓTICOS, COMPORTAMENTO ANIMAL, CANABINOIDES, MASTIGAÇÃO, DISCINESIA TARDIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONEGO, Andreza Buzolin e PRADO, Douglas da Silva e GUIMARÃES, Francisco Silveira. PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 111, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2021.110367. Acesso em: 08 jul. 2024.
APA
Sonego, A. B., Prado, D. da S., & Guimarães, F. S. (2021). PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111. doi:10.1016/j.pnpbp.2021.110367
NLM
Sonego AB, Prado D da S, Guimarães FS. PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110367
Vancouver
Sonego AB, Prado D da S, Guimarães FS. PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2021 ; 111[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2021.110367
Artigo de periodico
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms (2019)
Silote, Gabriela Pandini ; Sartim, Ariandra Guerini ; Sales, Amanda Juliana ; Eskelund, Amanda; Guimarães, Francisco Silveira; Wegener, Gregers; Wegener, Sâmia Regiane Lourenço Joca
Fonte: Journal of Chemical Neuroanatomy. Unidades: FMRP, FCFRP
Assuntos: ANTIDEPRESSIVOS, CANABINOIDES, DEPRESSÃO, NEUROQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILOTE, Gabriela Pandini et al. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. Journal of Chemical Neuroanatomy, v. 98, p. 104-116, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jchemneu.2019.04.006. Acesso em: 08 jul. 2024.
APA
Silote, G. P., Sartim, A. G., Sales, A. J., Eskelund, A., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2019). Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. Journal of Chemical Neuroanatomy, 98, 104-116. doi:10.1016/j.jchemneu.2019.04.006
NLM
Silote GP, Sartim AG, Sales AJ, Eskelund A, Guimarães FS, Wegener G, Wegener SRLJ. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms [Internet]. Journal of Chemical Neuroanatomy. 2019 ; 98 104-116.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.jchemneu.2019.04.006
Vancouver
Silote GP, Sartim AG, Sales AJ, Eskelund A, Guimarães FS, Wegener G, Wegener SRLJ. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms [Internet]. Journal of Chemical Neuroanatomy. 2019 ; 98 104-116.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.jchemneu.2019.04.006
Artigo de periodico
Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine (2019)
Ribeiro, Deidiane Elisa ; Casarotto, Plinio Cabrera ; Spiacci Junior, Ailton ; Fernandes, Gabriel Gripp ; Pinheiro, Lucas César; Santos, José Eduardo Tanus dos ; Zangrossi Junior, Hélio ; Guimarães, Francisco Silveira; Wegener, Sâmia Regiane Lourenço Joca ; Biojone, Caroline
Fonte: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FCFRP
Assuntos: ÓXIDO NÍTRICO, FÁRMACOS PSICOTRÓPICOS, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL, PÂNICO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 93, p. 232-239, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2019.04.007. Acesso em: 08 jul. 2024.
APA
Ribeiro, D. E., Casarotto, P. C., Spiacci Junior, A., Fernandes, G. G., Pinheiro, L. C., Santos, J. E. T. dos, et al. (2019). Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 93, 232-239. doi:10.1016/j.pnpbp.2019.04.007
NLM
Ribeiro DE, Casarotto PC, Spiacci Junior A, Fernandes GG, Pinheiro LC, Santos JET dos, Zangrossi Junior H, Guimarães FS, Wegener SRLJ, Biojone C. Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019 ; 93 232-239.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2019.04.007
Vancouver
Ribeiro DE, Casarotto PC, Spiacci Junior A, Fernandes GG, Pinheiro LC, Santos JET dos, Zangrossi Junior H, Guimarães FS, Wegener SRLJ, Biojone C. Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019 ; 93 232-239.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2019.04.007
Artigo de periodico
Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats (2019)
Hartmann, Alice; Fassini, Aline; Scopinho, América; Corrêa, Fernando Morgan de Aguiar ; Guimarães, Francisco Silveira ; Lisboa, Sabrina Francesca de Souza; Resstel, Leonardo Barbosa Moraes
Fonte: Journal of Psychopharmacology. Unidades: FMRP, FCFRP
Assuntos: ANSIEDADE, ESTRESSE, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARTMANN, Alice et al. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. Journal of Psychopharmacology, v. 33, n. 5, p. 606-614, 2019Tradução . . Disponível em: https://doi.org/10.1177/0269881119827799. Acesso em: 08 jul. 2024.
APA
Hartmann, A., Fassini, A., Scopinho, A., Corrêa, F. M. de A., Guimarães, F. S., Lisboa, S. F. de S., & Resstel, L. B. M. (2019). Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. Journal of Psychopharmacology, 33( 5), 606-614. doi:10.1177/0269881119827799
NLM
Hartmann A, Fassini A, Scopinho A, Corrêa FM de A, Guimarães FS, Lisboa SF de S, Resstel LBM. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats [Internet]. Journal of Psychopharmacology. 2019 ; 33( 5): 606-614.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1177/0269881119827799
Vancouver
Hartmann A, Fassini A, Scopinho A, Corrêa FM de A, Guimarães FS, Lisboa SF de S, Resstel LBM. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats [Internet]. Journal of Psychopharmacology. 2019 ; 33( 5): 606-614.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1177/0269881119827799

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos